US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
Patent 9345702 was granted and assigned to AbbVie Inc. on May, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 6, 2014
Date of Patent
May 24, 2016
Patent Applicant
Patent Application Number
14535070
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
